About Amide Technologies
Amide Technologies is a company based in Cambridge (United States) founded in 2017. Amide Technologies has raised $16.5 million across 3 funding rounds from investors including The Engine and Biological Engineering Ventures. The company has 8 employees as of December 31, 2022. Amide Technologies offers products and services including Peptide Synthesis Service and High-Speed Delivery Service. Amide Technologies operates in a competitive market with competitors including Nuclera Nucleics, Encodia, Tierra Biosciences, mk2 Biotechnologies and Kesmalea, among others.
- Headquarter Cambridge, United States
- Employees 8 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Amide Technologies Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.5 M (USD)
in 3 rounds
-
Latest Funding Round
$7.5 M (USD), Series A
Jul 01, 2023
-
Investors
The Engine
& 1 more
-
Employee Count
8
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amide Technologies
Amide Technologies offers a comprehensive portfolio of products and services, including Peptide Synthesis Service and High-Speed Delivery Service.
Synthesizes hard-to-obtain peptides for drug discovery and development.
Provides fast turnaround for urgent peptide orders in drug research.
People of Amide Technologies
Unlock access to complete
Unlock access to complete
Funding Insights of Amide Technologies
Amide Technologies has successfully raised a total of $16.5M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $7.5 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Amide Technologies
Amide Technologies has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include The Engine and Biological Engineering Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC funding and acceleration support are provided to tech startups.
|
Locked | Locked | Locked | |
|
Limited information is provided about Biological Engineering Ventures.
|
Locked | Locked | Locked |
Investor details for Amide Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amide Technologies
Investment portfolio details for Amide Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Amide Technologies
Detailed financials for Amide Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amide Technologies Comparisons
Peer comparison for Amide Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Amide Technologies
Amide Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuclera Nucleics, Encodia, Tierra Biosciences, mk2 Biotechnologies and Kesmalea, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Desktop bioprinter for genes and proteins production is developed.
|
|
| Locked | Locked | Locked |
Technology platforms for integrative proteomic analysis are developed.
|
|
| Locked | Locked | Locked |
AI-based tools for protein development and custom synthesis are offered.
|
|
| Locked | Locked | Locked |
Peptides and proteins are developed for life science applications.
|
|
| Locked | Locked | Locked |
Protein homeostasis modulators are developed for therapeutic applications.
|
Detailed competitors of Amide Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amide Technologies
Complete news archive for Amide Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amide Technologies
Amide Technologies was founded in 2017.
Amide Technologies is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Amide Technologies is a funded company, having raised a total of $16.5M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Amide Technologies is 8.
Amide Technologies was founded in 2017 and is based in Cambridge, United States. Operations focus on the biotechnology sector, where an automated platform for peptide synthesis is provided. A patent-protected instrument has been created to support solid-phase polypeptide synthesis through the integration of flow chemistry and precision reagents. This enables efficient production processes for research and development applications in the field.
Amide Technologies's top competitors include Nuclera Nucleics, Encodia and Tierra Biosciences.
Amide Technologies offers Peptide Synthesis Service and High-Speed Delivery Service.
Amide Technologies has 2 investors. Key investors include The Engine, and Biological Engineering Ventures.